Intervention not reported
Death from all causes · HIV‐positive people with tuberculous pericarditis. Most patients (80%) not on antiretroviral drugs
It is very uncertain whether the intervention changes death from all causes (very low certainty).
1 finding from 1 review
Intervention not reported
Death from pericarditis · HIV‐positive people with tuberculous pericarditis. Most patients (80%) not on antiretroviral drugs
It is very uncertain whether the intervention changes death from pericarditis (very low certainty).
1 finding from 1 review
Intervention not reported
Constrictive pericarditis · HIV‐positive people with tuberculous pericarditis. Most patients (80%) not on antiretroviral drugs
The intervention showed no clear difference in constrictive pericarditis (low certainty).
1 finding from 1 review
Intervention not reported
Repeat pericardiocentesis · HIV‐positive people with tuberculous pericarditis. Most patients (80%) not on antiretroviral drugs
The intervention showed no clear difference in repeat pericardiocentesis (low certainty).
1 finding from 1 review
Intervention not reported
Residual pleural fluid on chest X‐ray at 8 weeks · adults and adolescents with pleural TB
The intervention may leads to lower residual pleural fluid on chest X‐ray at 8 weeks (low certainty).
1 finding from 1 review
Intervention not reported
Residual pleural fluid on chest X‐ray at 24 weeks · adults and adolescents with pleural TB
The intervention may leads to lower residual pleural fluid on chest X‐ray at 24 weeks (low certainty).
1 finding from 1 review
Intervention not reported
Pleural changes at the end of · adults and adolescents with pleural TB
The intervention may leads to lower pleural changes at the end of (low certainty).
1 finding from 1 review
Intervention not reported
Long‐term functional respiratory impairment (> 6 months) · adults and adolescents with pleural TB
1 finding from 1 review
Intervention not reported
Adverse events leading to treatment discontinuation ( · adults and adolescents with pleural TB
The intervention may leads to higher adverse events leading to treatment discontinuation ( (low certainty).
1 finding from 1 review
Intervention not reported
HIV‐related infections (cryptococcal meningitis) · adults and adolescents with pleural TB
It is very uncertain whether the intervention changes HIV‐related infections (cryptococcal meningitis) (very low certainty).
1 finding from 1 review
Intervention not reported
HIV‐related cancer (Kaposi's sarcoma) · adults and adolescents with pleural TB
It is very uncertain whether the intervention changes HIV‐related cancer (Kaposi's sarcoma) (very low certainty).
1 finding from 1 review
Intervention not reported
HIV infection status of the child · HIV‐positive women during pregnancy and immediate postpartum period
The intervention showed no clear difference in HIV infection status of the child (moderate certainty).
1 finding from 1 review
Intervention not reported
Mean birthweight · HIV‐positive women during pregnancy and immediate postpartum period
The intervention showed no clear difference in mean birthweight (low certainty).
1 finding from 1 review
Intervention not reported
Low birthweight · HIV‐positive women during pregnancy and immediate postpartum period
The intervention probably leads to lower low birthweight (moderate certainty).
1 finding from 1 review
Intervention not reported
Child death by two years of age · HIV‐positive women during pregnancy and immediate postpartum period
The intervention showed no clear difference in child death by two years of age (low certainty).
1 finding from 1 review
Intervention not reported
Preterm delivery · HIV‐positive women during pregnancy and immediate postpartum period
It is very uncertain whether the intervention changes preterm delivery (very low certainty).
1 finding from 1 review
Intervention not reported
Stillbirth · HIV‐positive women during pregnancy and immediate postpartum period
It is very uncertain whether the intervention changes stillbirth (very low certainty).
1 finding from 1 review
Intervention not reported
Maternal death · HIV‐positive women during pregnancy and immediate postpartum period
It is very uncertain whether the intervention changes maternal death (very low certainty).
1 finding from 1 review
All‐cause mortality · adults with HIV infection
Multiple micronutrients showed no clear difference in mortality compared with placebo (low certainty).
1 finding from 1 review
Change in vitamin A concentrations (µmol/L) · adults with HIV infection
1 finding from 1 review